Pathological gambling and hypersexuality due to dopaminergic treatment in Parkinson's disease;Juego patológico e hipersexualidad debidos a tratamiento dopaminérgico en la enfermedad de parkinson

Actas Espanolas de Psiquiatria

Volumn 37, Issue 2, 2009, Pages 118-122

  González, T Martin ^a   Fernández, Francisco Martin ^a,b  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b El Majuelo   (Spain)

Author keywords

Antiparkinson agents; Parkinson's disease; Patological gambling; Sexual dysfunctions

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; SEXUAL DYSFUNCTION;

DOPAMINE AGENTS; GAMBLING; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 70350305456     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Courty E, Durif F, Zenut M, Courty P, Lavarenne J. The psychiatric and sexual disorders induced by apomorphine in Parkinson's Disease. Clin Neuropharmacol 1997;20(2):140-7.
2. Brown E, Brown G M, Kofman O, Quarrington B. Sexual function and affect in parkinsonian men treated with L-dopa. Am J Psychiatry 1978;135(12):1552-5.
3. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005;11(6):381-6.
4. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12(5):375-83.
5. Berger Ch, Mehrhoff FW, Beier KM, Meinck HM. Sexual delinquency and Parkinson's disease. Nervenarzt 2003;74(4):370-5.
6. Evans AH, Lees AJ. Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol 2004;17(4):393-8.
7. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neuro- surg Psychiatry 2000;68(4):423-8.
8. Molina JA, Siinz-Artiga MJ, Fraile A, Jimnez-Jimnez FJ, Villa- nueva C, Ortl-Pareja M, et al. Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment? Mov Disord 2000;15(5):869-72.
9. Lishman WA. Movement Disorders. En: Organic Psychiatry. Oxford: Blackwell Scientific Publications; 1987. p. 559-61.
10. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. Adv Neurol 1995;65:115- 38.
11. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62(9):1377-81.
12. Evans AH, Lawrence AD, Potts J, Apple S, Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005;65:1570-74.
13. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006 63(7):969-73.
14. Jimenez-Jimenez FJ, Sayed Y, Garcia-Soldevilla MA, Barcenilla B. Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 2002;36(7-8):1178-9.
15. Riley DE. Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline. Clin Neuropharmacol 2002;25(4):234-7..